{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Ivermectin", "query": { "condition": "Ivermectin" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 29, "total_pages": 3, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Ivermectin&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-04T17:35:10.458Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01066585", "title": "A Safety and Efficacy Study Comparing 0.5% Ivermectin Cream to a Vehicle Control in Subjects With Head Lice Infestation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Head Lice" ], "interventions": [ { "name": "Ivermectin Cream", "type": "DRUG" }, { "name": "vehicle control", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Topaz Pharmaceuticals Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Months", "maximum_age": null, "sex": "ALL", "summary": "6 Months and older" }, "enrollment_count": 410, "start_date": "2010-03", "completion_date": "2010-07", "has_results": true, "last_update_posted_date": "2012-04-06", "last_synced_at": "2026-09-04T17:35:10.458Z", "location_count": 8, "location_summary": "Yuma, Arizona • Dinuba, California • Plantation, Florida + 5 more", "locations": [ { "city": "Yuma", "state": "Arizona" }, { "city": "Dinuba", "state": "California" }, { "city": "Plantation", "state": "Florida" }, { "city": "West Palm", "state": "Florida" }, { "city": "Picayune", "state": "Mississippi" } ], "official_url": "https://clinicaltrials.gov/study/NCT01066585" }, { "nct_id": "NCT05894538", "title": "ACTIV-6: COVID-19 Study of Repurposed Medications - Arm D (Ivermectin 600)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Covid19" ], "interventions": [ { "name": "Ivermectin", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Susanna Naggie, MD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": null, "sex": "ALL", "summary": "30 Years and older" }, "enrollment_count": 1459, "start_date": "2022-02-16", "completion_date": "2022-10-30", "has_results": true, "last_update_posted_date": "2023-11-03", "last_synced_at": "2026-09-04T17:35:10.458Z", "location_count": 93, "location_summary": "Gilbert, Arizona • Mesa, Arizona • Peoria, Arizona + 81 more", "locations": [ { "city": "Gilbert", "state": "Arizona" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Peoria", "state": "Arizona" }, { "city": "Newport Beach", "state": "California" }, { "city": "North Hollywood", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05894538" }, { "nct_id": "NCT07795567", "title": "A Study Comparing Ivermectin Cream 1%, Soolantra™ Cream 1%, PrROSIVER® Cream1% to Placebo Control in the Treatment of Moderate to Severe Facial Rosacea.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Rosacea" ], "interventions": [ { "name": "Ivermectin Cream 1%", "type": "DRUG" }, { "name": "Soolantra™ Cream 1%", "type": "DRUG" }, { "name": "PrRosiver® Cream 1%", "type": "DRUG" }, { "name": "Placebo Control", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sun Pharmaceutical Industries, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 865, "start_date": "2025-12-09", "completion_date": "2026-06-24", "has_results": false, "last_update_posted_date": "2026-08-31", "last_synced_at": "2026-09-04T17:35:10.458Z", "location_count": 1, "location_summary": "Hawthorne, New York", "locations": [ { "city": "Hawthorne", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT07795567" }, { "nct_id": "NCT02509481", "title": "Repeat Ivermectin Mass Drug Administrations for Control of Malaria: a Pilot Safety and Efficacy Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Malaria", "Lymphatic Filariasis" ], "interventions": [ { "name": "Ivermectin", "type": "DRUG" }, { "name": "Albendazole", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Colorado State University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 2712, "start_date": "2015-06", "completion_date": "2015-12", "has_results": true, "last_update_posted_date": "2019-01-04", "last_synced_at": "2026-09-04T17:35:10.458Z", "location_count": 1, "location_summary": "Fort Collins, Colorado", "locations": [ { "city": "Fort Collins", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT02509481" }, { "nct_id": "NCT04530474", "title": "Outpatient Use of Ivermectin in COVID-19", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Covid19" ], "interventions": [ { "name": "Ivermectin Pill", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Temple University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2021-04-01", "completion_date": "2021-06-30", "has_results": false, "last_update_posted_date": "2021-05-26", "last_synced_at": "2026-09-04T17:35:10.458Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT04530474" }, { "nct_id": "NCT04885530", "title": "ACTIV-6: COVID-19 Study of Repurposed Medications", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Covid19" ], "interventions": [ { "name": "Ivermectin", "type": "DRUG" }, { "name": "Fluvoxamine", "type": "DRUG" }, { "name": "Fluticasone", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" }, { "name": "Montelukast", "type": "DRUG" }, { "name": "Metformin", "type": "DRUG" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Susanna Naggie, MD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": null, "sex": "ALL", "summary": "30 Years and older" }, "enrollment_count": 10956, "start_date": "2021-06-08", "completion_date": "2024-04-29", "has_results": true, "last_update_posted_date": "2025-11-17", "last_synced_at": "2026-09-04T17:35:10.458Z", "location_count": 110, "location_summary": "Chandler, Arizona • Gilbert, Arizona • Mesa, Arizona + 96 more", "locations": [ { "city": "Chandler", "state": "Arizona" }, { "city": "Gilbert", "state": "Arizona" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Peoria", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04885530" }, { "nct_id": "NCT00857948", "title": "Dose Ranging Study of Ivermectin Treatment Conditioner in Subjects With Head Lice Infestation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Pediculus Humanus Capitis (Head Lice)" ], "interventions": [ { "name": "ivermectin treatment conditioner", "type": "DRUG" }, { "name": "Placebo, vehicle control", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Topaz Pharmaceuticals Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Months", "maximum_age": null, "sex": "ALL", "summary": "6 Months and older" }, "enrollment_count": 78, "start_date": "2009-03", "completion_date": "2009-04", "has_results": true, "last_update_posted_date": "2012-03-30", "last_synced_at": "2026-09-04T17:35:10.458Z", "location_count": 1, "location_summary": "Miami, Florida", "locations": [ { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00857948" }, { "nct_id": "NCT05318469", "title": "Ivermectin in Combination With Balstilimab or Pembrolizumab in Patients With Metastatic Triple Negative Breast Cancer", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Anatomic Stage IV Breast Cancer AJCC v8", "Metastatic Triple-Negative Breast Carcinoma" ], "interventions": [ { "name": "Ivermectin", "type": "DRUG" }, { "name": "Balstilmab", "type": "DRUG" }, { "name": "Pembrolizumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Yuan Yuan", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 34, "start_date": "2023-10-13", "completion_date": "2026-10", "has_results": false, "last_update_posted_date": "2026-08-05", "last_synced_at": "2026-09-04T17:35:10.458Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05318469" }, { "nct_id": "NCT03605758", "title": "Treatment of Strongyloides Infection", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Strongyloides Stercoralis Infection", "Strongyloidiasis" ], "interventions": [ { "name": "Ivermectin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Albert Einstein College of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 51, "start_date": "2012-05", "completion_date": "2015-02-05", "has_results": true, "last_update_posted_date": "2023-11-30", "last_synced_at": "2026-09-04T17:35:10.458Z", "location_count": 1, "location_summary": "The Bronx, New York", "locations": [ { "city": "The Bronx", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT03605758" }, { "nct_id": "NCT05736861", "title": "ACTIV-6: COVID-19 Study of Repurposed Medications - Arm A (Ivermectin 400)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Covid19" ], "interventions": [ { "name": "Ivermectin", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Susanna Naggie, MD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": null, "sex": "ALL", "summary": "30 Years and older" }, "enrollment_count": 1800, "start_date": "2021-06-08", "completion_date": "2022-05-16", "has_results": true, "last_update_posted_date": "2023-06-13", "last_synced_at": "2026-09-04T17:35:10.458Z", "location_count": 87, "location_summary": "Gilbert, Arizona • Mesa, Arizona • Peoria, Arizona + 75 more", "locations": [ { "city": "Gilbert", "state": "Arizona" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Peoria", "state": "Arizona" }, { "city": "Newport Beach", "state": "California" }, { "city": "North Hollywood", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05736861" } ] }